Auricular Keloid Management: Clinical Outcome Of Intralesional Excision And Postoperative Triamcinolone Acetonide Intralesional Injection
Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of.
Background: Various treatments such as surgical excision, steroid injection, pressure therapy, and radiation therapy (RT) are available for auricular keloid. In particular, surgical excision in the treatment of auricular keloid is important, because recurrence rates are low compared to other sites. Objectives: We aimed to evaluate the clinical outcome of intralesional excision followed by postoperative triamcinolone acetonide intralesional injection (TA ILI) in the management of auricular keloid.Methods: We conducted a surgery records and charts review of patients who underwent auricular keloid management with intralesional excision and TA ILI. We also analyzed the recurrence rate over a 2-year period and evaluated the patient satisfaction using 11-point questionnaire (0-10).Results: A total of 18 Korean patients (2 males and 16 females), mean age of 26.5 years, with total 20 lesions were evaluated (2 patients had bilateral lesions). Lobular type (n= 10, 50%) was the most common, followed by anterior/posterior button (n= 3, 15%), wrap-around (n= 3, 15%), dumbbell (n= 2, 10%), and sessile type (n= 2, 10%). Total recurrence rate was 5% (1 of 20) within 24 months follow-up period, and mean satisfaction score was 9.6 (more than moderately satisfied). No serious and persistent adverse events were reported during the follow-up period.Conclusion: We confirmed that TA ILI after intralesional excision can be effective for auricular keloid management. With an effective surgical procedure and minimal postoperative treatment, a low recurrence rate close to that of postoperative RT was obtained.Key words: Auricle, ear, keloid, intralesional excision, intralesional injection, triamcinolone acetonide
Back to 2019 Posters